Actively Recruiting
Hospital @ Home Model of Care for Cirrhosis
Led by Indiana University · Updated on 2025-08-19
30
Participants Needed
1
Research Sites
190 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.
CONDITIONS
Official Title
Hospital @ Home Model of Care for Cirrhosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Enrolled into IUH's H@H program
- At least 18 years of age
- Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
- English speaking
- Able to provide consent
- Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge)
- Able to perform activities of daily living independently
- Lives within IU Health Home service area
You will not qualify if you...
- Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
- Transplant of organ other than liver
- Pregnant
- Incarcerated
- New hemodialysis
- Blood pressure less than 90/60, Pulse greater than 120, oxygen requirement greater than 6L or more than 2L above baseline
- HIV positive with CD4 count less than 200
- Receiving hospice services
- Concurrent enrollment in a related research study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IU School of Medicine
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Research Team
R
Regia Weber
CONTACT
A
Archita Desai, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here